カテゴリ： Research Dive, 世界, 医療/バイオ

アレルギー診断のグローバル市場2022-2031：インビボ、インビトロ

■ 英語タイトル：Allergy Diagnostic Market by Test Type (In Vivo and In Vitro), Product/Service (Consumables, Instruments, and Services), Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, and Other Allergens), End User (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022–2031

調査会社Research Dive社が発行したリサーチレポート（データ管理コード：RDV23MA014）■ 発行会社/調査会社：Research Dive
■ 商品コード：RDV23MA014
■ 発行日：2022年12月28日
■ 調査対象地域：グローバル
■ 産業分野：生命科学
■ ページ数：250
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD5,700 ⇒換算￥866,400見積依頼/購入/質問フォーム
5 UserUSD8,700 ⇒換算￥1,322,400見積依頼/購入/質問フォーム
Enterprise UserUSD10,700 ⇒換算￥1,626,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Research Dive社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[アレルギー診断のグローバル市場2022-2031：インビボ、インビトロ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Research Dive社によると、世界のアレルギー診断市場規模は2021年4,965.4百万ドルから2031年には16,714.2百万ドルまで、年平均13.2%の成長率を表すと見込まれます。本レポートでは、アレルギー診断の世界市場を調査・分析し、調査手法、調査範囲、エグゼクティブサマリー、市場概要、検査種類別（インビボ、インビトロ）分析、製品/サービス別（消耗品、機器、サービス）分析、アレルゲン別（吸入アレルゲン、食物アレルゲン、薬物アレルゲン、その他）分析、エンドユーザー別（診断検査室、病院検査室、学術研究機関、その他）分析、地域別（北米、欧州、アジア太平洋、中南米・中東・アフリカ）分析、競争状況など、以下のようにまとめました。本書の参入企業情報としては、Thermo Fisher Scientific, PerkinElmer Inc., Danaher, Hitachi Chemicals, BIOMÉRIEUX, Omega Diagnostics Group PLC, Siemens, Eurofins Scientific, Stallergenes Greer, and Neogen Corporation.などがあります。
・調査手法
・調査範囲
・エグゼクティブサマリー
・市場概要
・世界のアレルギー診断市場規模：検査種類別
- インビボ検査の市場規模
- インビトロ検査の市場規模
・世界のアレルギー診断市場規模：製品/サービス別
- 消耗品の市場規模
- 機器の市場規模
- サービスの市場規模
・世界のアレルギー診断市場規模：アレルゲン別
- 吸入アレルゲンの市場規模
- 食物アレルゲンの市場規模
- 薬物アレルゲンの市場規模
- その他アレルゲンの市場規模
・世界のアレルギー診断市場規模：エンドユーザー別
- 診断検査室における市場規模
- 病院検査室における市場規模
- 学術研究機関における市場規模
- その他エンドユーザーにおける市場規模
・世界のアレルギー診断市場規模：地域別
- 北米のアレルギー診断市場規模
- ヨーロッパのアレルギー診断市場規模
- アジア太平洋のアレルギー診断市場規模
- 中南米のアレルギー診断市場規模
- 中東/アフリカのアレルギー診断市場規模
・競争状況
・企業情報

According to Research Dive analysis, the global allergy diagnostic market is anticipated to generate a revenue of $16,714.2 million by 2031, increasing from $4,965.4 million in 2021, at a healthy CAGR of 13.2%.

COVID-19 Impact on the Global Allergy Diagnostic Market:
COVID-19 is a fatal condition that has devastated countless lives in an unprecedented way. The COVID-19 pandemic has triggered rapid changes in allergy diagnostic and immunology services. During this phase, many surgeries and other treatment procedures were canceled or postponed while doctors served as frontline warriors in the fight against COVID-19. Patients with a high severity of toxic immunotherapy and suffering from severe asthma allergies have received treatment by adopting protective measures including social distancing and wearing masks & PPE kits. Increase in COVID-19 cases across the globe and rise in number of people suffering from various allergies are projected to drive market demand.

Allergy Diagnostic Market Analysis:
The number of allergy sufferers around the globe is rapidly growing, and this trend is expected to continue in the coming years. The World Allergy Organization (WAO) anticipates allergy incidence rising by 15% to 40% in every country by 2030. According to the American College of Allergy, Asthma, and Immunology, over 50 million Americans are affected by allergens each year, and allergies are a major cause of chronic illness.
Significant investments and rigorous regulatory rules are the key elements that hinder industry expansion. Furthermore, installing and maintaining allergy diagnostic devices in laboratories is expensive, restricting the global allergy diagnostics market growth. In addition, the lack of experience in interpreting the reports and offering correct diagnoses has remained a tough factor in the business.
Furthermore, as technology advances, it presents significant potential opportunities for the market by introducing new blood tests and reducing risk. Moreover, the government’s increased support for developing low-income reimbursement schemes is driving up global allergy diagnostic market demand.

Based on test type, the in vitro sub-segment is predicted to show the fastest growth rate and generate revenue of $8,239.3 million by 2031.The absence of steroids or anti-histaminic effects, compatibility with any skin condition, and lack of risk of a systemic reaction are all advantages of in vitro testing.

Based on product & service, the consumables sub-segment is predicted to be the most dominant sub-segment and generate a revenue of $8,658.1 million by 2031, majorly due to the affordable prices and abundant reserves in various regions. Some of the factors driving market growth include an increase in the number of allergies that necessitate prompt diagnosis.

Based on allergen, the inhaled allergens sub-segment is predicted to be the most dominant sub-segment and generate a revenue of $6,968.6 million by 2031, due to the rising environmental pollution levels and rising pollen, coupled with other factors such as mold, fungus, and dust.
Based on end user, the diagnostic laboratories sub-segment of the global allergy diagnostic market is projected to have the fastest growth as well as dominant market share. It is also projected to surpass $8,199.8 million by 2031, with an increase from $2,334.6 million in 2021.The expansion of the sub-segment is mostly due to rising diagnostic laboratory trends because of patients’ demands for accurate diagnoses and an increase in the need for independent diagnostic laboratories. All these factors could raise demand for diagnostic laboratories and accelerate market growth.
Based on geographical scope, the Asia-Pacific allergy diagnostic market is anticipated to rise at a growth rate of 14.2%by 2031 from the revenue generated in 2021. This growth would be a result of increasing environmental pollution that can cause allergic diseases such as asthma.
The companies involved in the global allergy diagnostic market are Thermo Fisher Scientific, PerkinElmer Inc., Danaher, Hitachi Chemicals, BIOMÉRIEUX, Omega Diagnostics Group PLC, Siemens, Eurofins Scientific, Stallergenes Greer, and Neogen Corporation.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation

1.5.1.Top-down approach
1.5.2.Bottom-up approach

2.Report Scope

2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on Global Allergy Diagnostic Market

3.Executive Summary

4.Market Overview

4.1.Introduction
4.2.Growth impact forces

4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities

4.3.Market value chain analysis

4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors

4.4.Innovation & sustainability matrices

4.4.1.Technology matrix
4.4.2.Regulatory matrix

4.5.Porter’s five forces analysis

4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity

4.6.PESTLE analysis

4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.LEGAL
4.6.6.Environmental

4.7.Impact of COVID-19 on Allergy Diagnostic Market

4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario

5.Allergy Diagnostic Market Analysis, by Test Type

5.1.Overview
5.2.In Vivo

5.2.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.2.2.Market size analysis, by region, 2021-2031
5.2.3.Market share analysis, by country, 2021-2031

5.3. In Vitro

5.3.1.Definition, key trends, growth factors, and opportunities, 2021-2031
5.3.2.Market size analysis, by region, 2021-2031
5.3.3.Market share analysis, by country, 2021-2031

5.4.Research Dive Exclusive Insights

5.4.1.Market attractiveness, 2021-2031
5.4.2.Competition heatmap, 2021-2031

6.Allergy Diagnostic Market Analysis, by Product/Service

6.1.Overview
6.2.Consumables

6.2.1.Definition, key trends, growth factors, and opportunities, 2021-2031
6.2.2.Market size analysis, by region, 2021-2031
6.2.3.Market share analysis, by country, 2021-2031

6.3. Instruments

6.3.1.Definition, key trends, growth factors, and opportunities, 2021-2030
6.3.2.Market size analysis, by region, 2021-2031
6.3.3.Market share analysis, by country, 2021-2031

6.4.Services

6.4.1.Definition, key trends, growth factors, and opportunities, 2021-2030
6.4.2.Market size analysis, by region, 2021-2031
6.4.3.Market share analysis, by country, 2021-2031

6.5.Research Dive Exclusive Insights

6.5.1.Market attractiveness, 2021-2031
6.5.2.Competition heatmap, 2021-2031

7.Allergy Diagnostic Market Analysis, by Allergen

7.1.Inhaled Allergens

7.1.1.Definition, key trends, growth factors, and opportunities, 2021-2031
7.1.2.Market size analysis, by region, 2021-2031
7.1.3.Market share analysis, by country, 2021-2031

7.2.Food Allergens

7.2.1.Definition, key trends, growth factors, and opportunities, 2021-2031
7.2.2.Market size analysis, by region, 2021-2031
7.2.3.Market share analysis, by country, 2021-2031

7.3.Drug Allergens

7.3.1.Definition, key trends, growth factors, and opportunities, 2021-2031
7.3.2.Market size analysis, by region, 2021-2031
7.3.3.Market share analysis, by country, 2021-2031

7.4.Other Allergens

7.4.1.Definition, key trends, growth factors, and opportunities, 2021-2030
7.4.2.Market size analysis, by region, 2021-2031
7.4.3.Market share analysis, by country, 2021-2031

7.5.Research Dive Exclusive Insights

7.5.1.Market attractiveness, 2021-2031
7.5.2.Competition heatmap, 2021-2031

8.Allergy Diagnostic Market Analysis, by End-user

8.1.Diagnostic Laboratories

8.1.1.Definition, key trends, growth factors, and opportunities, 2021-2031
8.1.2.Market size analysis, by region, 2021-2031
8.1.3.Market share analysis, by country, 2021-2031

8.2. Hospital-based Laboratories

8.2.1.Definition, key trends, growth factors, and opportunities, 2021-2030
8.2.2.Market size analysis, by region, 2021-2031
8.2.3.Market share analysis, by country, 2021-2031

8.3.Academic Research Institutes

8.3.1.Definition, key trends, growth factors, and opportunities, 2021-2030
8.3.2.Market size analysis, by region, 2021-2031
8.3.3.Market share analysis, by country, 2021-2031

8.4.Others

8.4.1.Definition, key trends, growth factors, and opportunities, 2021-2030
8.4.2.Market size analysis, by region, 2021-2031
8.4.3.Market share analysis, by country, 2021-2031

8.5.Research Dive Exclusive Insights

8.5.1.Market attractiveness, 2021-2031
8.5.2.Competition heatmap, 2021-2031

9.Allergy Diagnostic Market, by Region

9.1.North America

9.1.1.U.S.

9.1.1.1.Market size analysis, by Test Type, 2021-2031
9.1.1.2.Market size analysis, by Product/Service, 2021-2031
9.1.1.3.Market size analysis, by Allergen, 2021-2031
9.1.1.4.Market size analysis, by End-user, 2021-2031

9.1.2.Canada

9.1.2.1.Market size analysis, by Test Type, 2021-2031
9.1.2.2.Market size analysis, by Product/Service, 2021-2031
9.1.2.3.Market size analysis, by Allergen, 2021-2031
9.1.2.4.Market size analysis, by End-user, 2021-2031

9.1.3.Mexico

9.1.3.1.Market size analysis, by Test Type, 2021-2031
9.1.3.2.Market size analysis, by Product/Service, 2021-2031
9.1.3.3.Market size analysis, by Allergen, 2021-2031
9.1.3.4.Market size analysis, by End-user, 2021-2031

9.1.4.Research Dive Exclusive Insights

9.1.4.1.Market attractiveness, 2021-2031
9.1.4.2.Competition heatmap, 2021-2031

9.2.Europe

9.2.1.Germany

9.2.1.1.Market size analysis, by Test Type, 2021-2031
9.2.1.2.Market size analysis, by Product/Service, 2021-2031
9.2.1.3.Market size analysis, by Allergen, 2021-2031
9.2.1.4.Market size analysis, by End-user, 2021-2031

9.2.2.UK

9.2.2.1.Market size analysis, by Test Type, 2021-2031
9.2.2.2.Market size analysis, by Product/Service, 2021-2031
9.2.2.3.Market size analysis, by Allergen, 2021-2031
9.2.2.4.Market size analysis, by End-user, 2021-2031

9.2.3.France

9.2.3.1.Market size analysis, by Test Type, 2021-2031
9.2.3.2.Market size analysis, by Product/Service, 2021-2031
9.2.3.3.Market size analysis, by Allergen, 2021-2031
9.2.3.4.Market size analysis, by End-user, 2021-2031

9.2.4.Spain

9.2.4.1.Market size analysis, by Test Type, 2021-2031
9.2.4.2.Market size analysis, by Product/Service, 2021-2031
9.2.4.3.Market size analysis, by Allergen, 2021-2031
9.2.4.4.Market size analysis, by End-user, 2021-2031

9.2.5.Italy

9.2.5.1.Market size analysis, by Test Type, 2021-2031
9.2.5.2.Market size analysis, by Product/Service, 2021-2031
9.2.5.3.Market size analysis, by Allergen, 2021-2031
9.2.5.4.Market size analysis, by End-user, 2021-2031

9.2.6.Rest of Europe

9.2.6.1.Market size analysis, by Test Type, 2021-2031
9.2.6.2.Market size analysis, by Product/Service, 2021-2031
9.2.6.3.Market size analysis, by Allergen, 2021-2031
9.2.6.4.Market size analysis, by End-user, 2021-2031

9.2.7.Research Dive Exclusive Insights

9.2.7.1.Market attractiveness, 2021-2031
9.2.7.2.Competition heatmap, 2021-2031

9.3.Asia-Pacific

9.3.1.China

9.3.1.1.Market size analysis, by Test Type, 2021-2031
9.3.1.2.Market size analysis, by Product/Service, 2021-2031
9.3.1.3.Market size analysis, by Allergen, 2021-2031
9.3.1.4.Market size analysis, by End-user, 2021-2031

9.3.2.Japan

9.3.2.1.Market size analysis, by Test Type, 2021-2031
9.3.2.2.Market size analysis, by Product/Service, 2021-2031
9.3.2.3.Market size analysis, by Allergen, 2021-2031
9.3.2.4.Market size analysis, by End-user, 2021-2031

9.3.3.India

9.3.3.1.Market size analysis, by Test Type, 2021-2031
9.3.3.2.Market size analysis, by Product/Service, 2021-2031
9.3.3.3.Market size analysis, by Allergen, 2021-2031
9.3.3.4.Market size analysis, by End-user, 2021-2031

9.3.4.Australia

9.3.4.1.Market size analysis, by Test Type, 2021-2031
9.3.4.2.Market size analysis, by Product/Service, 2021-2031
9.3.4.3.Market size analysis, by Allergen, 2021-2031
9.3.4.4.Market size analysis, by End-user, 2021-2031

9.3.5.South Korea

9.3.5.1.Market size analysis, by Test Type, 2021-2031
9.3.5.2.Market size analysis, by Product/Service, 2021-2031
9.3.5.3.Market size analysis, by Allergen, 2021-2031
9.3.5.4.Market size analysis, by End-user, 2021-2031

9.3.6.Rest of Asia-Pacific

9.3.6.1.Market size analysis, by Test Type, 2021-2031
9.3.6.2.Market size analysis, by Product/Service, 2021-2031
9.3.6.3.Market size analysis, by Allergen, 2021-2031
9.3.6.4.Market size analysis, by End-user, 2021-2031

9.3.7.Research Dive Exclusive Insights

9.3.7.1.Market attractiveness, 2021-2031
9.3.7.2.Competition heatmap, 2021-2031

9.4.LAMEA

9.4.1.Brazil

9.4.1.1.Market size analysis, by Test Type, 2021-2031
9.4.1.2.Market size analysis, by Product/Service, 2021-2031
9.4.1.3.Market size analysis, by Allergen, 2021-2031
9.4.1.4.Market size analysis, by End-user, 2021-2031

9.4.2.Saudi Arabia

9.4.2.1.Market size analysis, by Test Type, 2021-2031
9.4.2.2.Market size analysis, by Product/Service, 2021-2031
9.4.2.3.Market size analysis, by Allergen, 2021-2031
9.4.2.4.Market size analysis, by End-user, 2021-2031

9.4.3.UAE

9.4.3.1.Market size analysis, by Test Type, 2021-2031
9.4.3.2.Market size analysis, by Product/Service, 2021-2031
9.4.3.3.Market size analysis, by Allergen, 2021-2031
9.4.3.4.Market size analysis, by End-user, 2021-2031

9.4.4.South Africa

9.4.4.1.Market size analysis, by Test Type, 2021-2031
9.4.4.2.Market size analysis, by Product/Service, 2021-2031
9.4.4.3.Market size analysis, by Allergen, 2021-2031
9.4.4.4.Market size analysis, by End-user, 2021-2031

9.4.5.Rest of LAMEA

9.4.5.1.Market size analysis, by Test Type, 2021-2031
9.4.5.2.Market size analysis, by Product/Service, 2021-2031
9.4.5.3.Market size analysis, by Allergen, 2021-2031
9.4.5.4.Market size analysis, by End-user, 2021-2031

9.4.6.Research Dive Exclusive Insights

9.4.6.1.Market attractiveness, 2021-2031
9.4.6.2.Competition heatmap, 2021-2031

10.Competitive Landscape

10.1.Top winning strategies, 2021

10.1.1.By strategy
10.1.2.By year
10.2.Strategic overview
10.3.Market share analysis, 2021

11.Company Profiles

11.1. Thermo Fisher Scientific

11.1.1.Overview
11.1.2.Business segments
11.1.3.Product portfolio
11.1.4.Financial performance
11.1.5.Recent developments
11.1.6.SWOT analysis

11.2.Perkin Elmer PerkinElmer Inc.

11.2.1.Overview
11.2.2.Business segments
11.2.3.Product portfolio
11.2.4.Financial performance
11.2.5.Recent developments
11.2.6.SWOT analysis

11.3.Danaher

11.3.1.Overview
11.3.2.Business segments
11.3.3.Product portfolio
11.3.4.Financial performance
11.3.5.Recent developments
11.3.6.SWOT analysis

11.4. Hitachi Chemicals

11.4.1.Overview
11.4.2.Business segments
11.4.3.Product portfolio
11.4.4.Financial performance
11.4.5.Recent developments
11.4.6.SWOT analysis

11.5.BIOMÉRIEUX

11.5.1.Overview
11.5.2.Business segments
11.5.3.Product portfolio
11.5.4.Financial performance
11.5.5.Recent developments
11.5.6.SWOT analysis

11.6. Omega Diagnostics Group PLC

11.6.1.Overview
11.6.2.Business segments
11.6.3.Product portfolio
11.6.4.Financial performance
11.6.5.Recent developments
11.6.6.SWOT analysis

11.7.Siemens

11.7.1.Overview
11.7.2.Business segments
11.7.3.Product portfolio
11.7.4.Financial performance
11.7.5.Recent developments
11.7.6.SWOT analysis

11.8.Eurofins Scientific

11.8.1.Overview
11.8.2.Business segments
11.8.3.Product portfolio
11.8.4.Financial performance
11.8.5.Recent developments
11.8.6.SWOT analysis

11.9. Stallergenes Greer

11.9.1.Overview
11.9.2.Business segments
11.9.3.Product portfolio
11.9.4.Financial performance
11.9.5.Recent developments
11.9.6.SWOT analysis

11.10.Neogen Corporation.

11.10.1.Overview
11.10.2.Business segments
11.10.3.Product portfolio
11.10.4.Financial performance
11.10.5.Recent developments
11.10.6.SWOT analysis

12.Appendix

12.1.Parent & peer market analysis
12.2.Premium insights from industry experts
12.3.Related reports



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • アレルギー診断のグローバル市場（2020～2030）：インビボ、インビトロ
  • 早期毒性試験のグローバル市場：インビボ、インビトロ、インシリコ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(RDV23MA014 )"アレルギー診断のグローバル市場2022-2031：インビボ、インビトロ" (英文：Allergy Diagnostic Market by Test Type (In Vivo and In Vitro), Product/Service (Consumables, Instruments, and Services), Allergen (Inhaled Allergens, Food Allergens, Drug Allergens, and Other Allergens), End User (Diagnostic Laboratories, Hospital-based Laboratories, Academic Research Institutes, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022–2031)はResearch Dive社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。